Table 4.
Unhealed lesions at the end of chemotherapy in the two groups
Reasons for poor efficacy | Ultra-short-course chemotherapy group (cases) | Standard chemotherapy group (cases) | x2 | P |
---|---|---|---|---|
Multidrug-resistant TB | 3 | 2 | – | – |
Other parts of TB | 3 | 1 | – | – |
Severe liver and renal dysfunction | 0 | 2 | – | – |
Diabetes | 1 | 1 | – | – |
Rheumatic disease | 1 | 0 | – | – |
Total | 8 | 6 | 5.101 | 0.021 |